Browsing by Yonsei Author : Kim, Hye Ryun

eperson profile image
Name:
Kim, Hye Ryun [김혜련]
orcid http://orcid.org/0000-0002-1842-9070
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (8583782700)

Keyword Cloud

Researcher Network

Showing results 101 to 150 of 150

This table browses all dspace content
Issue DateTitleJournal Title
2016PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. ONCOTARGET
2016Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.LUNG CANCER
2016Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy.ONCOLOGY
2016A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to CrizotinibJOURNAL OF THORACIC ONCOLOGY
2016Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck SCIENTIFIC REPORTS
2016Serum PTHrP Predicts Weight Loss in Cancer Patients Independent of Hypercalcemia, Inflammation, and Tumor BurdenJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
2016Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation.TECHNOLOGY IN CANCER RESEARCH & TREATMENT
2016Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapyPHARMACOGENETICS AND GENOMICS
2015Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma ONCOTARGET
2015PD-1: Dual guard for immunopathology. ONCOTARGET
2015Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma MOLECULAR CANCER THERAPEUTICS
2015The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric CancerANNALS OF SURGICAL ONCOLOGY
2015Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cellsLUNG CANCER
2015Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine CANCER RESEARCH AND TREATMENT
2015An open label, multicenter, phase II study of dovitinib in advanced thyroid cancerEUROPEAN JOURNAL OF CANCER
2015The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancerLUNG CANCER
2015Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma. ONCOTARGET
2015Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neckCLINICAL CANCER RESEARCH
2014Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiencyEUROPEAN JOURNAL OF CANCER
2014Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements PLOS ONE
2014Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers GENOME MEDICINE
2014Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutationsLUNG CANCER
2014Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinomaLUNG CANCER
2014A prospective phase II trial of s-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2014Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinomaLUNG CANCER
2013Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patientsCANCER CHEMOTHERAPY AND PHARMACOLOGY
2013EGFR and TTF-1 Gene Amplification in Surgically Resected Lung Adenocarcinomas: Clinicopathologic Significance and Effect on Response to EGFR-Tyrosine Kinase Inhibitors in Recurred CasesANNALS OF SURGICAL ONCOLOGY
2013The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma ANNALS OF ONCOLOGY
2013Multicentre phase II trial of bevacizumab combined with docetaxel–carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905) ANNALS OF ONCOLOGY
2013Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerLUNG CANCER
2013The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma YONSEI MEDICAL JOURNAL
2013Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinomaFUTURE ONCOLOGY
2013Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung CancerJOURNAL OF CLINICAL ONCOLOGY
2013A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)LUNG CANCER
2012A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy.INVESTIGATIONAL NEW DRUGS
2012A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.INVESTIGATIONAL NEW DRUGS
2012The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2012Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. CANCER
2012Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancerANTICANCER RESEARCH
2011Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasisONCOLOGY
2011Treatment of recurrent hepatocellular carcinoma after liver transplantationASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2010Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinomaINTERNATIONAL JOURNAL OF HYPERTHERMIA
2009Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials. CANCER RESEARCH AND TREATMENT
2009Tension pneumopericardium after removal of pericardiocentesis drainage catheterCARDIOLOGY JOURNAL
2009Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma ANNALS OF ONCOLOGY
2009Clinical value of ezrin expression in primary osteosarcoma CANCER RESEARCH AND TREATMENT
2009Prognosis of pN3 stage gastric cancer CANCER RESEARCH AND TREATMENT
2009선천성 간경변증에서 발생한 국소결절증식양 결절 1예 Korean Journal of Medicine
2008결핵 환자에서 Rifampin에 의한 Henoch-Shonlein Purpura 1예 TUBERCULOSIS AND RESPIRATORY DISEASES
2007Transthoracic Echocardiographic Detection, Differential Diagnosis, and Follow-Up of Esophageal Hematoma KOREAN CIRCULATION JOURNAL

Browse

Links